Avalo Therapeutics, Inc. (AVTX)
7.30
-0.02
(-0.27%)
USD |
NASDAQ |
Nov 03, 11:42
Avalo Therapeutics Price : 7.30 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 7.13 | 7.46 | 7.000 | 7.32 | 1.619M |
| Oct 30, 2026 | 7.38 | 7.47 | 7.05 | 7.17 | 1.535M |
| Oct 29, 2026 | 7.18 | 7.708 | 7.18 | 7.44 | 2.274M |
| Oct 28, 2026 | 6.66 | 7.145 | 6.66 | 7.12 | 2.167M |
| Oct 27, 2026 | 6.91 | 6.98 | 6.58 | 6.75 | 2.643M |
| Oct 26, 2026 | 6.82 | 7.13 | 6.56 | 6.77 | 2.371M |
| Oct 23, 2026 | 7.27 | 7.50 | 6.53 | 6.93 | 4.551M |
| Oct 22, 2026 | 8.99 | 9.35 | 6.85 | 7.45 | 26.19M |
| Oct 21, 2026 | 12.41 | 13.18 | 12.22 | 12.26 | 930225.0 |
| Oct 20, 2026 | 11.61 | 12.85 | 11.26 | 12.36 | 1.870M |
| Oct 19, 2026 | 11.37 | 11.96 | 11.21 | 11.59 | 2.222M |
| Oct 16, 2026 | 12.05 | 12.05 | 11.23 | 11.27 | 971102.0 |
| Oct 15, 2026 | 11.93 | 12.34 | 11.70 | 12.01 | 936286.0 |
| Oct 14, 2026 | 11.90 | 12.12 | 11.58 | 11.84 | 1.237M |
| Oct 13, 2026 | 13.23 | 13.23 | 11.99 | 12.01 | 1.649M |
| Oct 12, 2026 | 13.56 | 13.69 | 13.13 | 13.24 | 502774.0 |
| Oct 09, 2026 | 13.42 | 13.82 | 13.36 | 13.65 | 648582.0 |
| Oct 08, 2026 | 13.45 | 13.60 | 12.77 | 13.43 | 990405.0 |
| Oct 07, 2026 | 13.43 | 13.98 | 13.30 | 13.58 | 719025.0 |
| Oct 06, 2026 | 14.58 | 14.58 | 13.23 | 13.59 | 955580.0 |
| Oct 05, 2026 | 15.09 | 15.09 | 14.39 | 14.60 | 736839.0 |
| Oct 02, 2026 | 15.05 | 15.16 | 14.31 | 14.99 | 948519.0 |
| Oct 01, 2026 | 15.24 | 15.57 | 14.78 | 14.95 | 932392.0 |
| Sep 30, 2026 | 15.80 | 15.99 | 15.14 | 15.33 | 1.433M |
| Sep 29, 2026 | 15.16 | 15.67 | 14.74 | 15.58 | 1.332M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 288.84 |
| ACADIA Pharmaceuticals, Inc. | 20.76 |
| Alnylam Pharmaceuticals, Inc. | 159.54 |
| Anika Therapeutics, Inc. | 19.27 |
| Savara, Inc. | 4.76 |
Price Related Metrics
| PS Ratio | 2976.36 |
| Price to Book Value | 0.8607 |
| Earnings Yield | -64.91% |
| Market Cap | 386.18M |